An observational study on changes in the Knee and Ankle functions after a knee Ligament surgery by using a muscle (Peroneus Longus) found in the same leg as a graft.
Not Applicable
- Conditions
- Health Condition 1: M235- Chronic instability of knee
- Registration Number
- CTRI/2019/01/017162
- Lead Sponsor
- Kasturba Hospital Manipal Academy of Higher Education
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Isolated ACL tears (including meniscus tears, if any)
2. The pateints undergoing Primary ACL reconstruction
3. No previous ankle instability or surgeries
Exclusion Criteria
1. Revision ACL surgery
2. Multi-ligament injury (associated Posterior Cruciate Ligament, Medial Collateral Ligament, Postero-Lateral Corner, & medial patella-femoral ligament injuries)
3. Patients who are involved in a high level of sports activities using ankle functions (footballers) or dancers
4. Incomplete follow-up
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Functional outcomes - Knee: International Knee Documentation Committee (IKDC) & Tegner Lysholm Scores <br/ ><br> <br/ ><br>2. Functional outcomes â?? Ankle: The American Orthopaedic Foot and Ankle score (AOFAS), Visual Analogue Scale â?? Foot and Ankle (VAS-FA), & EFAS (European Foot and Ankle Society) score. <br/ ><br>Timepoint: 1. Functional outcomes - Knee: International Knee Documentation Committee (IKDC) & Tegner Lysholm Scores <br/ ><br> <br/ ><br>2. Functional outcomes â?? Ankle: The American Orthopaedic Foot and Ankle score (AOFAS), Visual Analogue Scale â?? Foot and Ankle (VAS-FA), & EFAS (European Foot and Ankle Society) score. <br/ ><br>
- Secondary Outcome Measures
Name Time Method any complications in operated knee and/or ankle such as infection, neurological injury and wound related complications.Timepoint: In the immediate post-operative phase and in subsequent follow ups.